Abstract: An embodiment of a system for shunting aqueous humor from an anterior chamber of an eye includes an implant having an elongated body made of biocompatible material and a delivery device. At least a portion of the elongated body is implantable between a sclera and a ciliary body while the elongated body resides entirely within the confines of the sclera and a cornea with the proximal end of the implant being configured to reside within an anterior chamber angle and a lumen extending from at least one inlet port of the implant, through at least a portion of the elongated body, to one or more outlet ports of the implant so as to drain fluid from the anterior chamber toward a choroid of the eye. The delivery device includes an elongated member with a curved distal end portion to deliver the implant using an ab interno procedure.

Abstract: An air-stable, high-melt 1a-hydroxy-vitamin D3 compound, methods for preparing an animal feed composition, methods of preparing 1?-hydroxy-vitamin D3, methods of enhancing phytate phosphorus and calcium utilization, and an animal feed regime are provided.

Abstract: A module configured in operation to connect to a host, the module including: a decryptor operable to decrypt an encrypted transport stream received from the host, the transport stream including content data and a decryption seed; a decryption key generator operable to extract the decryption seed from the transport stream and to generate a decryption key from the decryption key seed; and a secure channel generator operable to generate a secure channel between the module and the host, whereby the secure channel generator is further operable to provide the generated decryption key to the host over the secure channel.

Abstract: Implants and methods for treating ocular disorders are provided. One method involves introducing an implant into an anterior chamber of an eye. The implant is implanted into eye tissue adjacent the anterior chamber such that a proximal end of the implant resides in the anterior chamber following implantation. A therapeutic agent is eluted from the implant into the eye. Desirably, the release of the therapeutic agent from the implant is controlled. The controlled release of the therapeutic agent can be at a chosen rate and/or for a selected duration which can be episodic or periodic. The therapeutic agent can be an antiproliferative agent, an anti-inflammatory drug, or a compound for treating glaucoma or ocular hypertension.

Abstract: An audio/video content delivery system includes a content source linked by an internet data connection to a content receiver, the content receiver configured to receive access-controlled encoded broadcast content from a content source by a separate broadcast data path. The content source includes an encryptor sending encrypted content to the content receiver according to a content encryption key. The content receiver includes: a host module including a decryptor decrypting encrypted content received from the content source; and a removable conditional access module (CAM) including an access control unit decoding the access-controlled encoded broadcast content, the host module and removable CAM configured to provide an encrypted communication link therebetween for decoded access-controlled encoded broadcast content. The content source and the CAM are configured to communicate to establish the key required by the decryptor in the host module to decrypt the encrypted content received from the content source.

Abstract: An apparatus and method for electrical charge balancing when generating a stimulus during functional neural stimulation is presented. A stimulus pulse is generated (cathodic or anodic), and after a selected delay a charge compensating pulse is generated of an opposite polarity. The electrode circuit discontinuously examines electrode voltage after termination of the stimulus pulse, and utilizes this voltage to determine how long to extend the width of the charge compensating pulse. The electrode circuit thus performs accurate electrical charge cancellation to remove residual charges from the electrode by precisely controlling pulse width for an opposing polarity compensating pulse that need not have the same current level as the stimulus pulse.

Abstract: Drainage of body fluid from an area of undesirably high pressure can be accomplished by interconnecting an artificial non-blood fluid conduit with the vascular system. For example, an artificial non-blood fluid conduit can be inserted into the eye to fluidly interconnect the anterior chamber with a location of lower pressure. The conduit can have a growth factor for stimulating growth of new blood vessels in the location of lower pressure to connect the new blood vessels with the non-blood fluid conduit.

Abstract: Methods are disclosed for treating glaucoma by treating a novel target. Methods for treating glaucoma by restoring the filtration capabilities of the endothelial lining of Schlemm's canal are provided. A method for identifying compounds capable of restoring the filtration capability of the juxtacanalicular meshwork is also provided.

Abstract: A tourniquet system for rapid automatic application of adequate pressure to stem bleeding of an injured limb while minimizing tissue damage due to excessive pressure. Pressure is supplied to the limb by inflation of a tourniquet cuff with compressed gas. The invention also relates to a method of controlling bleeding from a limb using the tourniquet system.

Abstract: Implants and methods for treating ocular disorders are provided. One method involves introducing an implant into an anterior chamber of an eye. The implant is implanted into eye tissue adjacent the anterior chamber such that a proximal end of the implant resides in the anterior chamber following implantation. A therapeutic agent is eluted from the implant into the eye. Desirably, the release of the therapeutic agent from the implant is controlled. The controlled release of the therapeutic agent can be at a chosen rate and/or for a selected duration which can be episodic or periodic. The therapeutic agent can be an antiproliferative agent, an anti-inflammatory drug, or a compound for treating glaucoma or ocular hypertension.

Abstract: A device to assist in the feeding of an infant from a bottle comprising a shoulder support pad shaped like a figure eight comprised of a washable material including a nonskid on the underside having ridges and valleys. A baby bottle holder is rotatably attached near one end of said shoulder support band. The caregiver can hold and support an infant in one arm and hand greatly reducing the effort required to feed an infant milk from a baby bottle.

Abstract: Semiconductor structures having a first layer including an n-type III-V semiconductor material and a second layer including an M(InP)(InGaAs) alloy, wherein M is selected from Ni, Pt, Pd, Co, Ti, Zr, Y, Mo, Ru, Ir, Sb, In, Dy, Tb, Er, Yb, and Te, and combinations thereof, are disclosed. The semiconductor structures have a substantially planar interface between the first and second layers. Methods of fabricating semiconductor structures, and methods of reducing interface roughness and/or sheet resistance of a contact are also disclosed.

Abstract: Semiconductor structures having a first layer including an n-type III-V semiconductor material and a second layer including an M(InP)(InGaAs) alloy, wherein M is selected from Ni, Pt, Pd, Co, Ti, Zr, Y, Mo, Ru, Ir, Sb, In, Dy, Tb, Er, Yb, and Te, and combinations thereof, are disclosed. The semiconductor structures have a substantially planar interface between the first and second layers. Methods of fabricating semiconductor structures, and methods of reducing interface roughness and/or sheet resistance of a contact are also disclosed.

Abstract: The present invention extends to methods, systems, and computer program products for domain controller safety-features and cloning. Embodiments include cloning virtual domain controllers. Cloning permits virtual domain controllers to be rapidly deployed by copying/cloning the entire operating system state of an existing virtual domain controller. Other embodiments provide safety features protecting domain controllers running within virtual machines from introducing distributed corruption into a directory services data system. Protection is facilitated by detecting when a hypervisor or Virtual Machine Manager (“VMM”) uses features that cause a virtual machine to be rolled back in time outside of an operating system's awareness. In response to detecting a feature that causes rollback, safeties can be implemented to compensate for otherwise divergent state and prevent the introduction of duplicate unique identifiers.

Abstract: Devices and methods for treating intraocular pressure are disclosed. The devices include shunts for draining aqueous humor from the anterior chamber to the uveoscleral outflow pathway, including the supraciliary space and the suprachoroidal space. The shunts are preferably implanted by ab interno procedures.

Abstract: Polymer composite roofing materials are provided which contain resin, and about 20-75 wt. % fillers and additives, in which the fillers contain at least one bulk filler for reducing the amount of resin needed to make the roofing material, and at least one aesthetically functional filler for providing the roofing material with an aesthetic appearance. The bulk filler and the aesthetically functional filler of this embodiment are non-toxic, resistant to microbial attack, and have a Mohs hardness of less than about 5.

Abstract: An audio/video content delivery system includes a content source linked by an internet data connection to a content receiver, the content receiver configured to receive access-controlled encoded broadcast content from a content source by a separate broadcast data path. The content source includes an encryptor sending encrypted content to the content receiver according to a content encryption key. The content receiver includes: a host module including a decryptor decrypting encrypted content received from the content source; and a removable conditional access module (CAM) including an access control unit decoding the access-controlled encoded broadcast content, the host module and removable CAM configured to provide an encrypted communication link therebetween for decoded access-controlled encoded broadcast content. The content source and the CAM are configured to communicate to establish the key required by the decryptor in the host module to decrypt the encrypted content received from the content source.

Abstract: A tunnel field-effect transistor is provided, which includes a fin-shaped, source-drain circuit structure with a source region and a drain region. The circuit structure is angled in cross-sectional elevation, and includes a first portion and a second portion. The first portion extends away from the second portion, and the source region is disposed in the first or second portion, and the drain region is disposed in the other of the first or second portion. The transistor further includes a gate electrode for gating the circuit structure and a self-aligned tunneling region. The tunneling region is self-aligned to at least a portion of the circuit structure and extends between the gate electrode and the first or second portion of the fin-shaped circuit structure, and the self-aligned tunneling region is at least partially disposed in parallel, spaced opposing relation to a control surface of the gate electrode.

Abstract: Methods are disclosed for treating glaucoma by treating a novel target. Methods for treating glaucoma by restoring the filtration capabilities of the endothelial lining of Schlemm's canal are provided. A method for identifying compounds capable of restoring the filtration capability of the juxtacanalicular meshwork is also provided.